SCHEMBL3589653

SCHEMBL3589653

O=C(Cn1ccc2cccc(-c3ccncc3)c21)NCCNCC1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.38
HSD17B10 Q99714 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
ROCK1 Q13464 1/20 0.38
NPY5R Q15761 1/20 0.37
KDM4E B2RXH2 5/20 0.36
HTT P42858 3/20 0.36
MAPT P10636 1/20 0.36
CNR1 P21554 2/20 0.36
CNR2 P34972 1/20 0.36
LMNA P02545 3/20 0.35
TSHR P16473 4/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HPGD P15428 1/20 0.35
EPHX2 P34913 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597289 0.91 ALDH1A1 (0.41) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3592317 0.91 KDM4E (0.41) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3596540 0.90 HSD17B10 (0.37) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3608260 0.89 GRIN2B (0.42) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3608180 0.89 HTT (0.45) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3594707 0.89 NPC1 (0.41) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3605625 0.88 MGLL (0.38) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3605921 0.86 EPHX2 (0.41) ALDH1A1NPY5RKDM4EHTTSMN1; SMN2
SCHEMBL3605994 0.85 PIM1 (0.42) HSD17B10ALDH1A1MAPK1NPY5RKDM4E
SCHEMBL3589635 0.84 NPY5R (0.41) HSD17B10ALDH1A1MAPK1NPY5RKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 ROCK2 850/4885HSD17B10 3413/4885ALDH1A1 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.